Spero Therapeutics (SPRO) Q4 2025 Earnings

13NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.55
-0.38
-0.2
-0.03

Details

Expected EPS
-0.25
Actual EPS
-0.13
Surprise EPS
0.12
Surprise Percent
+48%

Description

Spero Therapeutics (SPRO) has reported earnings of -0.13 per share for Q4 2025.

0 Comments

Share your thoughts